Document is current
Any future updates will be listed below
-
Authors
Blaabjerg, Lasse M.
Jonsson, Nicolas https://orcid.org/0000-0002-7838-1814
Boomsma, Wouter https://orcid.org/0000-0002-8257-3827
Stein, Amelie https://orcid.org/0000-0002-5862-1681
Lindorff-Larsen, Kresten https://orcid.org/0000-0002-4750-6039
-
Funding
Funding for this research was provided by:
Novo Nordisk Fonden (NNF18OC0033950)
Novo Nordisk Fonden (NNF20OC0062606)
Carlsbergfondet (CF21-0392)
- License Information
-
More Information
Article History
Received: 21 January 2024
Accepted: 28 October 2024
First Online: 7 November 2024
Competing interests
: K.L.L. holds stock options and is a consultant for Peptone Ltd. All other authors declare no competing interests.
